Lv11
10 积分 2026-03-06 加入
Prospective randomized pilot study of Y90 +/− sorafenib as bridge to transplantation in hepatocellular carcinoma
1小时前
待确认
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience
1小时前
已完结
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial
2小时前
已完结
High-protein diets alleviate tumour growth and drug resistance by promoting AKT aggregation and turnover
3个月前
已完结
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia
3个月前
已完结
皖公网安备34019202002308
